Breaking News, Collaborations & Alliances

Avantor, Cytovance Biologics Enter Plasmid DNA Development Pact

Will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avantor, a global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, and Cytovance Biologics, a biologics contract development and manufacturing organization (CDMO) specializing in the manufacturing of high-quality plasmid DNA have entered into an agreement to manufacture research and GMP grade plasmids for biopharma customers. This collaboration extends Avantor’s leadership in providing critical mat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters